Researchers have demonstrated that dynamic single-photon emission computed tomography combined with computerised tomography, known as SPECT/CT, with kinetic modelling can distinguish tracer delivery from tracer washout kinetics. By applying compartmental kinetic modelling to imaging data, the team characterised tracer influx and efflux in tumour-infiltrating chimeric antigen receptor T cells, or CAR T cells. This approach provides a more sophisticated biological interpretation of tumour uptake than static imaging alone, offering a proof-of-concept for quantitative cell-tracking strategies in solid tumour therapy evaluation.
The study addresses significant challenges in the application of CAR T cell therapies to solid tumours. These therapies often face inefficient trafficking to the tumour site, limited extravasation from blood vessels, and impaired persistence within the immunosuppressive tumour microenvironment. Non-invasive imaging approaches that capture the dynamic behaviour and biodistribution of these cells are needed to better understand these barriers. The research explores the use of compartmental modelling to interpret the uptake of technetium-99m pertechnetate, abbreviated as [99mTc]TcO4−, by CAR T cells that co-express the sodium iodide symporter, or NIS, reporter gene.
The investigation was conducted in a prostate cancer model using NOD scid gamma, or NSG, mice. The team engineered CAR T cells to target prostate-specific membrane antigen, or PSMA, while simultaneously expressing the human NIS reporter gene. This co-expression allowed for the non-invasive visualisation of CAR T cell infiltration in vivo. The researchers confirmed that adding the hNIS gene did not impair the function of the CAR T cells.
Dynamic SPECT/CT imaging revealed clear differences in tumour uptake between mice treated with CAR-hNIS T cells and control groups. The imaging data was analysed using a reversible two-compartment framework. The compartmental modelling demonstrated increased tracer influx and reduced tracer efflux in the tumours of CAR-hNIS treated mice.
These kinetic changes indicate that the tumour signal arises from NIS-mediated tracer uptake and delayed tracer washout in tumours containing infiltrating CAR T cells. The findings suggest that the observed signal is not merely the result of passive perfusion or non-specific delivery of the tracer. By distinguishing tracer delivery from tracer washout kinetics, the approach corrects for variability in tracer bioavailability.
Immunohistochemistry was used to confirm the presence of CAR T cell infiltration in the tumours, providing histological validation of the imaging findings.
The work highlights the potential of integrating kinetic modelling into future quantitative cell-tracking strategies. Such strategies could improve the evaluation and optimisation of CAR T cell therapies for solid tumours.
Subject of Research: Kinetic modelling of dynamic SPECT imaging for tracking CAR T cell infiltration in solid tumours
Article Title: Dynamic SPECT imaging kinetic modelling characterises tracer influx and efflux in tumour-infiltrating CAR T cells
Article References: Bugallo-Blanco, E., Taprogge, J., Murray, I., Cleaver, J., Page, R., Martinez, O., Sosabowski, J., & Papa, S. (2026). Dynamic SPECT imaging kinetic modelling characterises tracer influx and efflux in tumour-infiltrating CAR T cells. EJNMMI Research. https://doi.org/10.1186/s13550-026-01492-y
Image Credits: AI Generated
DOI: 10.1186/s13550-026-01492-y
Keywords: CAR T cells, SPECT/CT, kinetic modelling, solid tumours, prostate cancer, NIS reporter, technetium-99m, cell tracking, immunotherapy, tracer influx, tracer efflux, Dynamic
News Source: Nathaniel Bowman. (November 10, 2026). Kinetic Modelling Tracks CAR T Cell Infiltration in Tumours. Scienmag.



